Ayala Pharmaceuticals (ADXS) Competitors

Ayala Pharmaceuticals (NASDAQ:ADXS) and Organovo (NASDAQ:ONVO) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends.

Do institutionals and insiders have more ownership in ADXS or ONVO?

7.2% of Ayala Pharmaceuticals shares are held by institutional investors. Comparatively, 8.2% of Organovo shares are held by institutional investors. 0.6% of Ayala Pharmaceuticals shares are held by insiders. Comparatively, 3.7% of Organovo shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Does the media favor ADXS or ONVO?

In the previous week, Organovo had 8 more articles in the media than Ayala Pharmaceuticals. MarketBeat recorded 9 mentions for Organovo and 1 mentions for Ayala Pharmaceuticals. Organovo's average media sentiment score of 0.60 beat Ayala Pharmaceuticals' score of 0.00 indicating that Organovo is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ayala Pharmaceuticals	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Organovo	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer ADXS or ONVO?

Organovo received 196 more outperform votes than Ayala Pharmaceuticals when rated by MarketBeat users. Likewise, 46.01% of users gave Organovo an outperform vote while only 0.00% of users gave Ayala Pharmaceuticals an outperform vote.

Company	Underperform	Outperform
Ayala Pharmaceuticals	Outperform Votes No Votes	Underperform Votes 80 100.00%
Organovo	Outperform Votes 196 46.01%	Underperform Votes 230 53.99%

Which has more volatility and risk, ADXS or ONVO?

Ayala Pharmaceuticals has a beta of 1.68, meaning that its share price is 68% more volatile than the S&P 500. Comparatively, Organovo has a beta of 0.45, meaning that its share price is 55% less volatile than the S&P 500.

Which has higher valuation & earnings, ADXS or ONVO?

Organovo has lower revenue, but higher earnings than Ayala Pharmaceuticals. Organovo is trading at a lower price-to-earnings ratio than Ayala Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ayala Pharmaceuticals	$3.24M	0.59	-$48.07M	-$7.98	-0.01
Organovo	$122K	33.60	-$14.67M	-$10.20	-0.24

Is ADXS or ONVO more profitable?

Ayala Pharmaceuticals has a net margin of 0.00% compared to Organovo's net margin of -10,151.64%. Ayala Pharmaceuticals' return on equity of 0.00% beat Organovo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ayala Pharmaceuticals	N/A	N/A	N/A
Organovo	-10,151.64%	-346.26%	-187.53%

Summary

Organovo beats Ayala Pharmaceuticals on 8 of the 15 factors compared between the two stocks.